4.6 Article

Aquagenic pruritus in polycythemia vera: Characteristics and influence on quality of life in 441 patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Safety and Efficacy of TG101348, a Selective JAK2 Inhibitor, in Myelofibrosis

Animesh Pardanani et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Letter Medicine, General & Internal

Long-Term Outcome of Treatment with Ruxolitinib in Myelofibrosis

Ayalew Tefferi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2011)

Review Medicine, General & Internal

Polycythemia vera-associated pruritus and its management

Kamal S. Saini et al.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)

Article Medicine, General & Internal

Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis.

Srdan Verstovsek et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Hematology

Pruritus in polycythemia vera is associated with a lower risk of arterial thrombosis

Naseema Gangat et al.

AMERICAN JOURNAL OF HEMATOLOGY (2008)

Article Pathology

Mast cell distribution in normal adult skin

AS Janssens et al.

JOURNAL OF CLINICAL PATHOLOGY (2005)

Article Hematology

Pruritus in polycythaemia vera: prevalence, laboratory correlates and management

F Diehn et al.

BRITISH JOURNAL OF HAEMATOLOGY (2001)